Thiel, Bezos Back Startup Treating Tumors With Sound Waves

Peter Thiel and Jeff Bezos are investing in HistoSonics Inc., a healthcare startup valued at $3 billion, which is pioneering a groundbreaking technology that uses sound waves to treat tumors. This innovative approach could revolutionize cancer treatment, offering a non-invasive alternative that may improve patient outcomes and reduce recovery times. The backing from such high-profile investors highlights the potential impact of this technology in the medical field.